| CMIDX | PEMGX | CMIDX / PEMGX | |
| Total Expense Ratio | 1.08 | 0.90 | 120% |
| Annual Report Gross Expense Ratio | 1.08 | 0.90 | 120% |
| Fund Existence | 14 years | 21 years | - |
| Gain YTD | 16.074 | -0.810 | -1,984% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2000 | 1000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 372M | 23.2B | 2% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -1.62 | -10.28 | 16% |
| Returns for 3 years | -10.31 | 20.27 | -51% |
| Returns for 5 years | -37.85 | -1.03 | 3,679% |
| Returns for 10 years | 32.21 | 80.30 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GLNBX | 22.87 | 0.15 | +0.66% |
| MFS Global New Discovery B | |||
| MGISX | 28.80 | 0.18 | +0.63% |
| Morgan Stanley Inst Global Franchise R6 | |||
| PNAIX | 80.96 | 0.51 | +0.63% |
| T. Rowe Price All-Cap Opportunities-I | |||
| TWQCX | 19.69 | 0.10 | +0.51% |
| Transamerica Large Cap Value C | |||
| QKBGX | 24.07 | 0.08 | +0.33% |
| Federated Hermes MDT Balanced R6 | |||